Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Moleculin Biotech, Inc. (MBRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/15/2022 |
4/A
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,584 shares
@ $1.47, valued at
$5.3k
Exercised 14,717 restricted stock units
@ $0 |
|
| 07/15/2022 |
4/A
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,215 shares
@ $1.68, valued at
$5.4k
Exercised 13,205 restricted stock units
@ $0 |
|
| 07/15/2022 |
4/A
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 225,000 options to buy
@ $1.49, valued at
$335.3k
Granted 225,000 restricted stock units
@ $0 |
|
| 07/15/2019 |
4/A
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.82, valued at
$910k
|
|
|
|